Bad news for Johnson & Johnson's vaccine
from a team of New York University researchers found the one-shot Johnson & Johnson vaccine is far less effective at preventing coronavirus infections from the Delta variant and other mutated forms of the virus than from earlier strains, a concerning find since the Delta variant now accounts for almost all U.S. Covid-19 cases....
Clinical trials put the J&J vaccine's efficacy at around 66% against the original coronavirus strain, while the two-shot Pfizer and Moderna vaccines were more than 90% effective.Tuesday the Delta variant now makes up around 83% of all Covid cases in the United States.published by Johnson & Johnson, which suggested the vaccine was effective against Delta and other new variants.
. The number actually represents just a small slice of around 161.5 million Americans who have been fully vaccinated.Rising cases, hospitalizations and deaths across the U.S. are fueling concerns about another major Covid spike. Numerous cities and localities are now urging all residents to wear
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Johnson & Johnson Vaccine Far Less Effective Against Delta Variant, Study SuggestsMore than 13 million Americans have received the J&J vaccine.
Consulte Mais informação »
Pfizer Shot Just 39% Effective Against Delta Infection, But Largely Prevents Severe Illness, Israel Study SuggestsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Consulte Mais informação »
Is J&J's COVID-19 shot good enough? Experts say yes but want more data.Studies suggest the J&J vaccine may provide somewhat less protection, particularly against the delta variant, which now accounts for more than 80% of COVID-19 cases across the United States.
Consulte Mais informação »
Pfizer Shot Just 39% Effective Against Delta Infection, But Largely Prevents Severe Illness, Israel Study SuggestsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Consulte Mais informação »
Most vaccines offer protection against Delta variant with just 1 dose: StudyA Canadian study found that protection against the Delta variant was 56% effective against symptomatic infection after one dose of the BioNTech/Pfizer vaccine. Moderna was 72% effective and Oxford/AstraZeneca 67% effective.
Consulte Mais informação »
Does America face a slowdown in economic growth?Even if vaccines eliminate the need to return to strict measures, consumers may become too anxious to visit bars and restaurants
Consulte Mais informação »